Inherited white matter disorders: Hypomyelination (myelin disorders)
- PMID: 39322379
- DOI: 10.1016/B978-0-323-99209-1.00014-4
Inherited white matter disorders: Hypomyelination (myelin disorders)
Abstract
Hypomyelinating leukodystrophies are a subset of genetic white matter diseases characterized by insufficient myelin deposition during development. MRI patterns are used to identify hypomyelinating disorders, and genetic testing is used to determine the causal genes implicated in individual disease forms. Clinical course can range from severe, with patients manifesting neurologic symptoms in infancy or early childhood, to mild, with onset in adolescence or adulthood. This chapter discusses the most common hypomyelinating leukodystrophies, including X-linked Pelizaeus-Merzbacher disease and other PLP1-related disorders, autosomal recessive Pelizaeus-Merzbacher-like disease, and POLR3-related leukodystrophy. PLP1-related disorders are caused by hemizygous pathogenic variants in the proteolipid protein 1 (PLP1) gene, and encompass classic Pelizaeus-Merzbacher disease, the severe connatal form, PLP1-null syndrome, spastic paraplegia type 2, and hypomyelination of early myelinating structures. Pelizaeus-Merzbacher-like disease presents a similar clinical picture to Pelizaeus-Merzbacher disease, however, it is caused by biallelic pathogenic variants in the GJC2 gene, which encodes for the gap junction protein Connexin-47. POLR3-related leukodystrophy, or 4H leukodystrophy (hypomyelination, hypodontia, and hypogonadotropic hypogonadism), is caused by biallelic pathogenic variants in genes encoding specific subunits of the transcription enzyme RNA polymerase III. In this chapter, the clinical features, disease pathophysiology and genetics, imaging patterns, as well as supportive and future therapies are discussed for each disorder.
Keywords: 4H leukodystrophy; Connexin-47; HEMS; Hypomyelination of early myelinating structures; PLP1-related disorders; POLR3-related leukodystrophy; Pelizaeus–Merzbacher disease; Pelizaeus–Merzbacher-like disease; Proteolipid protein; RNA polymerase III.
Copyright © 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Similar articles
-
Neurogenetics of Pelizaeus-Merzbacher disease.Handb Clin Neurol. 2018;148:701-722. doi: 10.1016/B978-0-444-64076-5.00045-4. Handb Clin Neurol. 2018. PMID: 29478609 Free PMC article. Review.
-
Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.Brain. 2015 Sep;138(Pt 9):2521-36. doi: 10.1093/brain/awv204. Epub 2015 Jul 15. Brain. 2015. PMID: 26179919 Free PMC article.
-
Novel mutations in the GJC2 gene associated with Pelizaeus-Merzbacher-like disease.Mol Biol Rep. 2019 Aug;46(4):4507-4516. doi: 10.1007/s11033-019-04906-4. Epub 2019 Jul 3. Mol Biol Rep. 2019. PMID: 31270756
-
The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.Med Wieku Rozwoj. 2013 Oct-Dec;17(4):293-300. Med Wieku Rozwoj. 2013. PMID: 24519770
-
Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.Adv Exp Med Biol. 2019;1190:201-216. doi: 10.1007/978-981-32-9636-7_13. Adv Exp Med Biol. 2019. PMID: 31760646 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
